Junping Wei
Overview
Explore the profile of Junping Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei S, Jiang W, Zheng H, Zhang J, Yang J, Wang Y, et al.
Diabetol Metab Syndr
. 2025 Feb;
17(1):48.
PMID: 39920852
Objective: Previous studies have emphasized the independent effects of anthropometric indices-including body mass index (BMI), A Body Shape Index (ABSI), waist-to-height ratio (WHtR), body roundness index (BRI), and Conicity Index-on...
2.
Wei S, Pan X, Xiao Y, Wei J
BMC Cardiovasc Disord
. 2025 Jan;
25(1):46.
PMID: 39849364
Objective: Arteriosclerosis plays a significant role as one of the key pathological mechanisms underlying Diabetic Kidney Disease (DKD). The estimated Pulse Wave Velocity (ePWV) is used to assess arteriosclerosis, and...
3.
Systemic inflammation response index association with gout in hyperuricemic adults: NHANES 2007-2018
Tian X, Zeng G, Wei J
Front Med (Lausanne)
. 2025 Jan;
11():1490655.
PMID: 39845814
Background: Hyperuricemia is the underlying condition of gout. Previous studies have indicated that specific strategies may be effective in preventing the progression of hyperuricemia to gout. However, there is a...
4.
Marek R, Halabi S, Wang M, McBane J, Wei J, Wang T, et al.
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591176
: Androgen receptor (AR) expression and signaling are critical for the progression of prostate cancer and have been the therapeutic focus of prostate cancer for over 50 years. While a...
5.
Wei S, Pan X, Wei J
BMC Endocr Disord
. 2024 Sep;
24(1):179.
PMID: 39237970
Objective: The prevalence of type 2 diabetes mellitus (T2DM) and bone metabolism disorders increase with age. Diabetic kidney disease (DKD) is one of the most serious microvascular complications of T2DM,...
6.
Zeng G, Lin Y, Xie P, Lin J, He Y, Wei J
Exp Gerontol
. 2024 Aug;
195:112557.
PMID: 39181192
Objective: A considerable percentage of individuals with chronic kidney disease (CKD) are reported to be frail. Lower physical activity and higher sedentary time are most consistently associated with frailty among...
7.
Association between serum vitamin D level and Graves' disease: a systematic review and meta-analysis
Pang B, Li L, Liu X, Cao Z, Pang T, Wang Q, et al.
Nutr J
. 2024 Jun;
23(1):60.
PMID: 38849834
Objective: This meta-analysis aims to analyze the relationship between serum vitamin D (VD) levels and Graves' disease (GD). Methods: We conducted a search for publications on VD and GD in...
8.
Zeng G, Lin Y, Xie P, Lin J, He Y, Wei J
J Multidiscip Healthc
. 2024 May;
17:2461-2473.
PMID: 38799017
Background: To investigate the association between the NLR and the risk of all-cause and cardiovascular mortality in US adults with diabetic kidney disease (DKD). Methods: The data utilized for this...
9.
Wei S, Pan X, Xiao Y, Chen R, Wei J
Front Endocrinol (Lausanne)
. 2024 May;
15:1345293.
PMID: 38726343
Objective: The activation of platelets in individuals with type 2 diabetes mellitus (T2DM) triggers inflammation and hemodynamic abnormalities, contributing to the development of diabetic kidney disease (DKD). Despite this, research...
10.
Dailey G, Rabiola C, Lei G, Wei J, Yang X, Wang T, et al.
Hum Vaccin Immunother
. 2024 Feb;
20(1):2309693.
PMID: 38330990
ER+ breast cancers (BC) are characterized by the elevated expression and signaling of estrogen receptor alpha (, which renders them sensitive to anti-endocrine therapy. While these therapies are clinically effective,...